Plus, it can help you recover more quickly following a workout
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes, Obesity and Metabolism
Reducing cravings: 91% of participants experienced fewer food cravings, with 86% noting reduced sugar cravings over 3 months
Semaglutide helps with long-term results, by supporting sustained weight loss over longer periods of time when combined with a healthy diet and regular physical activity
Sections were incubated with 5% normal rat serum followed by further incubation
14-16 For patients receiving either a GLP-1 RA or an SGLT2 inhibitor for CV risk reduction, the ADA recommends considering the addition of the other class if benefits outweigh risks (e.g., if already on a GLP-1 RA, add an SGLT2 inhibitor with proven CV benefit or vice versa) in addition to optimizing other guideline-directed medical therapies for prevention ( Figure 4 )